parkinson's disease retatrutide clinical trial A Big Week for GLP-1 Drugs - by Eric Topol Amantadine DR/ER Efficacy as Early

Tirzepatide reduced the apnea-hypopnea index by about 25 to 29 events per hour from baselines of roughly 50 events per hour, a reduction of about half, alongside substantial weight loss

As a lactation consultant, Ive had more and more moms ask about these medications

The dual GLP-1/amylin mechanism approaches this therapeutic ceiling by multiple and non-overlapping pathways that do not involve compensatory mechanisms that limit the efficacy of single-hormone therapy

GLP-1 receptor agonists mimic this hormone, leading to: Reduced hunger and cravings Improved insulin sensitivity Slower gastric emptying (helping you feel full longer) Fat loss without extreme caloric restriction Can GLP-1 Cause Muscle Loss

Proc Natl Acad Sci U S A 89: 8641-8645, 1992